GPX4 and osteosarcoma: Moreover, in osteosarcoma cells, overactivation of STAT3/NRF2 signaling can lead to cisplatin resistance by increasing glutathione peroxidase 4 (GPX4) activity, thereby suppressing ferroptosis [135].